CYCLOPENTOLATE USE DİSORDER: A CASE REPORT OF INTRANASAL MİSUSE

Yasemin Görgülü; Işıl Çöl Ateş; Rugül Köse Çınar; Mehmet Bülent Sönmez

CYCLOPENTOLATE USE DİSORDER: A CASE REPORT OF INTRANASAL MİSUSE

Authors

Yasemin Görgülü Trakya University, School ofMedicine, Department of Psychiatry
Işıl Çöl Ateş Psychiatrist, Inegol State Hospital
Rugül Köse Çınar Trakya University, School ofMedicine, Department of Psychiatry
Mehmet Bülent Sönmez Trakya University, School ofMedicine, Department of Psychiatry

Keywords:

Cyclopentolate, use disorder, intranasal, bipolar disorder

Abstract

Anti-cholinergic drugs carry dependency risk. Cyclopentolate is a topical anticholinergic drug commonly used in ophthalmology clinics which possesses mydriatic and cycloplegic properties. A 28 year old male patient previously diagnosed with bipolar disorder was admitted to the psychiatric clinic with symptoms of depression. We learned that he has been using cylo-pentolate containing eye drops intranasally for pleasure for about one year. Hereby, we have reported a cyclopentolate use disorder case with comorbid bipolar disorder, which used cyclopentolate intranasally, different to other cases in the literature.

References

Pullen GP, Best NR, Maguire J. Anticholinergic drug abuse: a common problem. British Medical Journal 1984; 289: 612-613.

Espi Martinez F, Espi Forcen F, Shapov A, Martinez Moya A. Biperiden dependence: case report and literature review. Case Rep Psychiatry 2012; 2012: 949256.

Buhrich N, Weller A, Kevans P. Misuse of anticholinergic drugs by people with serious mental illness. Psychiatry Serv 2000; 51: 928-929.

Gjerden P, Bramness JG, Slordal L. The use and potential abuse of anticholinergic antiparkinson drugs in Norway: a pharmacoepidemiological study. Br J Clin Pharmacol 2008; 67: 228-233.

Ağın H, Gerçek H, Kutlu A, ve ark. Delirium induced by topical cyclopentolate use: a case report. Çocuk Sağlığı ve Hastalıkları Dergisi 2008; 51: 39-42.

Ostler HB. Cycloplegics and mydriatics. Tolerance, habituation, and addiction to topical administration. Arch Ophthalmol1975;93:423-513.

Sato EH, de Freitas D, Foster CS. Abuse of cyclopentolate hydrochloride (Cyclogyl) drops. New Engl J Med 1992; 326: 1363-1364.

Akkaya C, Zorlu Kocagoz S, Sarandol A. Addiction to topically used cyclopentolate hydrochloride: a case report. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 1752-1753.

Darcin AE, Dilbaz N, Yilmaz S, Cetin MK. Cyclopentolate hydrochloride eye drops addiction: A Case Report. J Addict Med 2011; 5: 84-85.

Miller NS, Guttman JC. The integration of pharmacological therapy for comor- bid psychiatric and addictive disorders. J Psychoactive Drugs 1997; 29: 249-254.

McElroy SL, Altshuler LL, Suppes T, et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry 2001; 158: 420-426.

Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry. 1985; 142: 1259-1264.

Thornton LK, Baker AL, Johnson MP, et al. Reasons for substance use among people with psychotic disorders: method triangulation approach. Psychol Addict Behav. 2012; 26: 279-288.

Spencer C, Castle D, Michie PT. Motivations that maintain substance use among individuals with psychotic disorders. Schizophr Bull. 2002; 28: 233-247.

Bersani FS, Corazza O, Simonato P, et al. Drops of madness? Recreational misuse of tropicamide collyrium; early warning alerts from Russia and Italy. Gen Hosp Psychiatry. 2013; 5: 571-573.

Janowsky DS, el-Yousef MK, Davis JM, Sekerke HJ. A cholinergic-adrenergic hypothesis of mania and depression. Lancet 1972; 2: 632-635.

Pettersen H, Ruud T, Ravnda lE, Landheim A.Walk-ing the fine line: self-reported reasons for substance use in persons with severe mental illness. IntJ Qual Stud Health Well-being. 2013; 8: 21968.

Pierce RC, Kumaresan V. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse? Neurosci Biobehav Rev. 2006; 30: 215-238.

Lester DB, Rogers TD, Blaha CD. Acetylcholine-dopamine interactions in the pathophysiology and treatment of CNS disorders. CNS Neurosci Ther. 2010; 16: 137-162.

Weiss RD, Griffin ML, Mirin SM. Drug abuse as self medication for depression: an empirical study. Am J Drug Alcohol Abuse 1992; 18: 121-129.

Fleck DE, Arndt S, DelBello MP, Strakowski SM. Concurrent tracking of alcohol use and bipolar disorder symptoms. Bipolar Disord 2006; 8: 338-344.

CYCLOPENTOLATE USE DİSORDER: A CASE REPORT OF INTRANASAL MİSUSE